# A Randomized Study to Evaluate the Efficacy of Insulclock® in Patients With Uncontrolled Type 2 Diabetes

> **NCT03224234** · NA · COMPLETED · sponsor: **Emory University** · enrollment: 121 (actual)

## Conditions studied

- Diabetes

## Interventions

- **DEVICE:** Insulclock with feedback
- **DEVICE:** Insulclock without feedback

## Key facts

- **NCT ID:** NCT03224234
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-29
- **Primary completion:** 2019-09-18
- **Final completion:** 2019-09-18
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2021-01-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03224234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03224234, "A Randomized Study to Evaluate the Efficacy of Insulclock® in Patients With Uncontrolled Type 2 Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03224234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*